We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
+3%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
AUM
$3.1B
AUM Growth
-$435M
Cap. Flow
-$287M
Cap. Flow %
-9.25%
Top 10 Hldgs %
90.28%
Holding
51
New
2
Increased
2
Reduced
9
Closed
15

Top Buys

Rank Stock Value
1
BULL
Webull Corp
BULL
+$512M
2
PDD icon
Pinduoduo
PDD
+$43.5M
3
CWAN
Clearwater Analytics
CWAN
+$31.4M
4
FUTU icon
Futu Holdings
FUTU
+$485K

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$327M
2
NTES icon
NetEase
NTES
+$116M
3
BEKE icon
KE Holdings
BEKE
+$86.7M
4
JD icon
JD.com
JD
+$86.5M
5
VIPS icon
Vipshop
VIPS
+$78.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 31.41%
2 Healthcare 19.95%
3 Financials 17.24%
4 Technology 17.2%
5 Communication Services 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDD icon
1
Pinduoduo
PDD
$122B
$730M 23.52%
6,976,804
+414,228
+6% +$43.5M
FUTU icon
2
Futu Holdings
FUTU
$17.4B
$533M 17.17%
4,312,237
+4,745
+0.1% +$485K
BULL
3
Webull Corp
BULL
$4.96B
$396M 12.74%
+33,080,846
New +$512M
ONC
4
BeOne Medicines Ltd
ONC
$41.5B
$250M 8.06%
1,034,306
NTES icon
5
NetEase
NTES
$78.6B
$224M 7.21%
1,663,668
-1,005,029
-38% -$116M
LEGN icon
6
Legend Biotech
LEGN
$3.87B
$212M 6.84%
5,984,550
BEKE icon
7
KE Holdings
BEKE
$20.2B
$132M 4.27%
7,465,465
-4,507,937
-38% -$86.7M
BABA icon
8
Alibaba
BABA
$296B
$130M 4.2%
1,149,700
-2,758,055
-71% -$327M
AVBP icon
9
ArriVent BioPharma
AVBP
$1.49B
$97.6M 3.14%
4,484,672
WNS
10
DELISTED
WNS Holdings
WNS
$96.8M 3.12%
1,531,466
JD icon
11
JD.com
JD
$38.8B
$74.3M 2.39%
2,275,500
-2,536,200
-53% -$86.5M
YSG
12
Yatsen Holding
YSG
$285M
$58.9M 1.9%
6,111,933
-773,940
-11% -$4.43M
CWAN
13
DELISTED
Clearwater Analytics
CWAN
$30M 0.96%
+1,365,971
New +$31.4M
CTKB icon
14
Cytek Biosciences
CTKB
$608M
$22.6M 0.73%
6,657,030
VIPS icon
15
Vipshop
VIPS
$6.42B
$17M 0.55%
1,131,788
-5,552,113
-83% -$78.6M
LI icon
16
Li Auto
LI
$12B
$16.8M 0.54%
620,000
NBP
17
NovaBridge Biosciences American Depositary Shares
NBP
$213M
$14.5M 0.47%
5,980,568
ZTO icon
18
ZTO Express
ZTO
$16.3B
$11.9M 0.38%
671,387
BZ icon
19
Kanzhun
BZ
$7.95B
$10.3M 0.33%
576,339
API
20
Agora
API
$347M
$8M 0.26%
2,098,553
GOSS icon
21
Gossamer Bio
GOSS
$83.2M
$6.12M 0.2%
4,974,041
MAZE
22
Maze Therapeutics
MAZE
$1.52B
$5.61M 0.18%
457,535
SGMT icon
23
Sagimet Biosciences
SGMT
$656M
$5.52M 0.18%
724,800
EM
24
DELISTED
Smart Share Global Ltd
EM
$4.5M 0.15%
3,949,700
TUYA
25
Tuya Inc
TUYA
$1.15B
$3.61M 0.12%
1,564,400

Similar funds

HHLR Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, HHLR Advisors held 51 positions worth $3.1B, down 12% from $3.54B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

HHLR Advisors withdrew a net $287M in Q2 2025, closing 15 positions and reducing 9 holdings. Its most notable exit was Trip.com Group, an estimated $59.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, down from 48% a quarter earlier, followed by Healthcare and Financials.

Against the trend, HHLR Advisors opened a new position in Webull Corp worth $396M.

  • HHLR Advisors's largest Q2 2025 buy was Webull Corp: 33,080,846 shares worth $396M.
  • HHLR Advisors added most to Pinduoduo in Q2 2025, an estimated $43.5M increase.
  • HHLR Advisors's biggest Q2 2025 reduction was Alibaba, cutting an estimated $327M.
  • HHLR Advisors fully exited Trip.com Group in Q2 2025, selling an estimated $59.7M.
  • HHLR Advisors's ten largest holdings make up 90% of its $3.1B portfolio in Q2 2025.
  • HHLR Advisors opened 2 new positions and closed 15 in Q2 2025.
  • HHLR Advisors's portfolio value fell 12% quarter-over-quarter to $3.1B.

Based on HHLR Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.